Neoplasma

Titel Veröffentlichungsdatum Sprache Zitate
Clinical utility of the interaction between lectin and serum prostate specific antigen in prostate cancer2009/01/0110
Hormonal and metabolic evaluation of adrenal incidentalomas2009/01/0110
Ovarian cancer: Origin and factors involved in carcinogenesis with potential use in diagnosis, treatment and prognosis of the disease2011/01/019
Endoglin and CD-34 immunoreactivity in the assessment of microvessel density in normal pituitary and adenoma subtypes2010/01/019
E-Cadherin truncation and Sialyl Lewis-X overexpression in oral squamous cell carcinoma and oral precancerous conditions2009/01/019
Characterization of Pulmonary Lesions with Low F-18 FDG Uptake Using Double Phase F-18 FDG PET/CT: Comparison of Visual and Quantitative Analyses2009/01/019
Evaluation of TNF superfamily molecules release by neutrophils and B leukemic cells of patients with chronic B – cell lymphocytic leukemia2011/01/019
Synthetic isothiocyanate indole-3-ethyl isothiocyanate (homoITC) enhances sensitivity of human ovarian carcinoma cell lines A2780 and A2780/CP to cisplatin2010/01/019
17β-hydroxysteroid dehydrogenase type 11 (Pan1b) expression in human prostate cancer2009/01/019
Mechanism of betulinic acid inhibition of collagen biosynthesis in human endometrial adenocarcinoma cells2009/01/019
The importance of serum levels of selected biological parameters in the diagnosis, staging and prognosis of multiple myeloma2010/01/019
Polymorphisms of biotransforming enzymes (GSTs) and their association with colorectal cancer in the Slovak population2009/01/018
The Glu346Lys polymorphism and frameshift mutations of the Methyl-CpG Binding Domain 4 gene in gastrointestinal cancer2009/01/018
The Role of PPARs in MDR – a lesson from embryonic development2009/01/018
The utility of 99mTc-EDDA/HYNIC-TOC scintigraphy for assessment of lung lesions in patients with neuroendocrine tumors2010/01/018
Serum level of IGFBP3 and IGF1/IGFBP3 molar ratio in addition to PSA and single nucleotide polymorphism in PSA and CYP17 gene may contribute to early diagnostics of prostate cancer2010/01/018
Molecular predictive factors of outcome of radiotherapy in cervical cancer2011/01/018
Immunophenotyping parameters as prognostic factors in T-acute leukemia patients2009/01/018
Association of Toll like receptor 9 expression with lymph node metastasis in human breast cancer2011/01/018
D-dimer, plasminogen activator inhibitor-1, prothrombin fragments and protein C – role in prothrombotic state of colorectal cancer.2011/01/018
Cisplatin-based chemotherapy in elderly patients with advanced stage (IIIB and IV) non-small cell lung cancer patients2011/04/288
Prognostic stratification using F-18 FDG PET/CT in patients with advanced stage (Stage III and IV) non-small cell lung cancer2010/01/018
EGFR and HER-2 status of non-small cell lung cancer brain metastasis and corresponding primary tumor2011/01/018
Autologous Hsp70 immunization induces anti-tumor immunity and increases longevity and survival of tumor-bearing mice2009/01/018
High dose rate versus low dose rate brachytherapy in the treatment of tongue carcinoma – a radiobiological study2009/01/018
Anal cancer chemoirradiation with curative intent – a single institution experience2009/01/018
Fine-needle aspiration biopsy of cervical lymph nodes: factors in predicting malignant diagnosis2011/01/017
Transcription factor IIH – the protein complex with multiple functions2010/01/017
CCND1 and ZNF217 gene amplification is equally frequent in BRCA1 and BRCA2 associated and non-BRCA breast cancer2010/01/017
Population-based study of BRCA1/2 mutations: Family history based criteria identify minority of mutation carriers2010/01/017